| Literature DB >> 26691952 |
Pilar Brito-Zerón1, Elke Theander2, Chiara Baldini3, Raphaèle Seror4,5, Soledad Retamozo1,6, Luca Quartuccio7, Hendrika Bootsma8, Simon J Bowman9, Thomas Dörner10, Jacques-Eric Gottenberg11, Xavier Mariette4,5, Stefano Bombardieri3, Salvatore de Vita7, Thomas Mandl2, Wan-Fai Ng12, Aike A Kruize13, Athanasios Tzioufas14, Claudio Vitali15, Jill Buyon16, Peter Izmirly16, Robert Fox17, Manuel Ramos-Casals1.
Abstract
Sjögren's syndrome (SjS) is a systemic autoimmune disease that mainly affects the exocrine glands, leading to generalized mucosal dryness. However, primary SjS may initially present with non-sicca (systemic) manifestations. When these features appear before the onset of an overt sicca syndrome, we may talk of an underlying 'occult' SjS. The European League Against Rheumatism (EULAR) has promoted and supported an international collaborative study group (EULAR-SS Task Force) aimed at developing consensual recommendations to provide a homogeneous approach to the patient with primary SjS presenting with systemic involvement. This review summarizes the key factors that should be taken into account in the diagnostic approach in a patient with suspected SjS according to the main clinical patterns of presentation, and is especially focused on organ-specific systemic disease presentations, including a consensus set of recommendations in order to reach an early diagnosis. Close collaboration with the different specialties involved through a comprehensive multidisciplinary approach is essential in SjS patients presenting with systemic involvements.Entities:
Keywords: ESSDAI; Sjögren syndrome; anti-Ro/SS-A antibodies; classification criteria; early diagnosis; focal lymphocytic sialadenitis; systemic activity
Mesh:
Year: 2015 PMID: 26691952 DOI: 10.1586/1744666X.2016.1109449
Source DB: PubMed Journal: Expert Rev Clin Immunol ISSN: 1744-666X Impact factor: 4.473